PharmaCorp Rx Inc. (TSXV:PCRX)
0.415
0.00 (0.00%)
At close: Dec 5, 2025
PharmaCorp Rx Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Cash & Equivalents | 5.02 | 12.89 | 2.24 | 2.73 | 0.98 |
| Cash & Short-Term Investments | 5.02 | 12.89 | 2.24 | 2.73 | 0.98 |
| Cash Growth | -81.16% | 474.84% | -17.99% | 178.91% | - |
| Receivables | 0.79 | 0.33 | - | - | - |
| Inventory | 2.46 | 1.31 | - | - | - |
| Prepaid Expenses | 0.19 | 0.05 | - | - | - |
| Other Current Assets | - | - | 0.08 | - | 0.02 |
| Total Current Assets | 8.46 | 14.57 | 2.32 | 2.73 | 1 |
| Property, Plant & Equipment | 4.23 | 4.02 | - | - | - |
| Goodwill | 14.03 | 11.48 | - | - | - |
| Other Intangible Assets | 7.95 | 5.13 | - | - | - |
| Total Assets | 39.71 | 35.21 | 2.32 | 2.73 | 1 |
| Accounts Payable | 2.84 | 1.54 | 0.05 | 0.02 | 0.03 |
| Current Portion of Long-Term Debt | 0.4 | 0.08 | - | - | - |
| Current Portion of Leases | 0.09 | 0.07 | - | - | - |
| Current Income Taxes Payable | 0.01 | 0.01 | - | - | - |
| Total Current Liabilities | 3.34 | 1.7 | 0.05 | 0.02 | 0.03 |
| Long-Term Debt | 3.15 | 0.32 | - | - | - |
| Long-Term Leases | 0.68 | 0.49 | - | - | - |
| Long-Term Deferred Tax Liabilities | 2.33 | 2.14 | - | - | - |
| Total Liabilities | 9.5 | 4.64 | 0.05 | 0.02 | 0.03 |
| Common Stock | 31.7 | 31.7 | 2.8 | 2.74 | 1 |
| Additional Paid-In Capital | 0.88 | 0.67 | 0.49 | 0.52 | - |
| Retained Earnings | -2.6 | -2.03 | -1.01 | -0.54 | -0.03 |
| Total Common Equity | 29.98 | 30.34 | 2.27 | 2.72 | 0.97 |
| Minority Interest | 0.23 | 0.22 | - | - | - |
| Shareholders' Equity | 30.21 | 30.57 | 2.27 | 2.72 | 0.97 |
| Total Liabilities & Equity | 39.71 | 35.21 | 2.32 | 2.73 | 1 |
| Total Debt | 4.32 | 0.95 | - | - | - |
| Net Cash (Debt) | 0.71 | 11.93 | 2.24 | 2.73 | 0.98 |
| Net Cash Growth | -97.25% | 432.33% | -17.99% | 178.91% | - |
| Net Cash Per Share | 0.01 | 0.15 | 0.11 | 0.14 | 0.06 |
| Filing Date Shares Outstanding | 117.3 | 117.3 | 20.28 | 20 | 16.17 |
| Total Common Shares Outstanding | 117.3 | 117.3 | 20.28 | 20 | 16.17 |
| Working Capital | 5.12 | 12.88 | 2.27 | 2.72 | 0.97 |
| Book Value Per Share | 0.26 | 0.26 | 0.11 | 0.14 | 0.06 |
| Tangible Book Value | 8 | 13.73 | 2.27 | 2.72 | 0.97 |
| Tangible Book Value Per Share | 0.07 | 0.12 | 0.11 | 0.14 | 0.06 |
| Land | 0.25 | 0.25 | - | - | - |
| Buildings | 2.85 | 2.85 | - | - | - |
| Machinery | 0.26 | 0.13 | - | - | - |
| Leasehold Improvements | 0.31 | 0.31 | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.